scispace - formally typeset
Open AccessJournal ArticleDOI

Global estimates of cancer prevalence for 27 sites in the adult population in 2008

Reads0
Chats0
TLDR
The latest estimates of global cancer incidence and survival were used to update previous figures of limited duration prevalence to the year 2008 and highlight the need for long‐term care targeted at managing patients with certain very frequently diagnosed cancer forms.
Abstract
Recent estimates of global cancer incidence and survival were used to update previous figures of limited duration prevalence to the year 2008. The number of patients with cancer diagnosed between 2004 and 2008 who were still alive at the end of 2008 in the adult population is described by world region, country and the human development index. The 5-year global cancer prevalence is estimated to be 28.8 million in 2008. Close to half of the prevalence burden is in areas of very high human development that comprise only one-sixth of the world's population. Breast cancer continues to be the most prevalent cancer in the vast majority of countries globally; cervix cancer is the most prevalent cancer in much of Sub-Saharan Africa and Southern Asia and prostate cancer dominates in North America, Oceania and Northern and Western Europe. Stomach cancer is the most prevalent cancer in Eastern Asia (including China); oral cancer ranks as the most prevalent cancer in Indian men and Kaposi sarcoma has the highest 5-year prevalence among men in 11 countries in Sub-Saharan Africa. The methods used to estimate point prevalence appears to give reasonable results at the global level. The figures highlight the need for long-term care targeted at managing patients with certain very frequently diagnosed cancer forms. To be of greater relevance to cancer planning, the estimation of other time-based measures of global prevalence is warranted.

read more

Citations
More filters
Journal ArticleDOI

Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer.

TL;DR: Circulating miR-551b-5p was a novel promising biomarker for the detection of GC and exploration of the molecular mechanisms of miR+5p is useful to search for new therapeutic strategies of GC.
Journal ArticleDOI

Estimating radiotherapy demands in South East Asia countries in 2025 and 2035 using evidence-based optimal radiotherapy fractions.

TL;DR: The radiotherapy demand in countries in Southeast Asia in 2025 and 2035 is quantified using evidence‐based optimal radiotherapy fractions to estimate the demand for radiotherapy in these countries.

Development of microfluidic tools to reproduce and characterize the tumor microenvironment

TL;DR: The use of microfluidic models for the desarrollo of new farmacos against cancer in vitro mas precisos has been discussed in this article, with the aim of reproducir and caracterizing the microentorno tumoral.
Journal ArticleDOI

Therapeutic positioning of secretory acetylated APE1/Ref-1 requirement for suppression of tumor growth in triple-negative breast cancer in vivo

TL;DR: The stimulation of apoptosis by the binding of secreted acetylated-apurinic apyrimidinic endonuclease 1/redox factor-1 to the receptor for advanced glycation end products (RAGE) was essential for TNBC cell death in response to hyperacetylation.
Journal ArticleDOI

Effectiveness of an educational intervention among public health midwives on breast cancer early detection in the district of Gampaha, Sri Lanka.

TL;DR: This planned educational intervention had a significant impact on improving KAP of PHMs for early detection of breast cancer in the Gampaha district.
References
More filters
Journal ArticleDOI

Global cancer statistics

TL;DR: A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
Journal ArticleDOI

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI

Global cancer statistics, 2002.

TL;DR: There are striking variations in the risk of different cancers by geographic area, most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
Journal ArticleDOI

Projections of the Cost of Cancer Care in the United States: 2010–2020

TL;DR: The national cost of cancer care is substantial and expected to increase because of population changes alone, and the total cost in 2020 is projected to be $173 billion, which represents a 39% increase from 2010.
Journal ArticleDOI

Cancer burden in the year 2000. The global picture.

TL;DR: Three elementary measures of cancer frequency are confined ourselves to: incidence, mortality and prevalence.
Related Papers (5)
Trending Questions (3)
What are the current statistics on advanced cancer prevalence worldwide?

In 2008, global cancer prevalence was estimated at 28.8 million, with breast cancer most prevalent globally, cervix cancer in Sub-Saharan Africa and Southern Asia, and prostate cancer in North America.

What is the current 5-year prevalence of cancer in Europe?

The 5-year prevalence of cancer in Europe is not explicitly mentioned in the provided abstract and title.

How cancer is prevalant worlwide?

The paper provides estimates of global cancer prevalence in adults in 2008. It states that the 5-year global cancer prevalence was estimated to be 28.8 million in 2008. It also mentions that breast cancer is the most prevalent cancer globally, while cervix cancer is the most prevalent in Sub-Saharan Africa and Southern Asia, and prostate cancer dominates in North America, Oceania, and Northern and Western Europe.